胰高血糖素样肽-1对心血管系统的保护效应

被引:6
作者
刘琳
严宗逊
机构
[1] 川北医学院附属医院
关键词
胰高血糖素样肽-1; 血管内皮细胞; 糖尿病; 心血管系统;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
100201 [内科学];
摘要
糖尿病患者的高糖、高脂状态可直接影响心血管系统,引起心血管并发症,且目前的治疗方法不能完全防止血管并发症的发生,严重危害患者的生命健康。近年来,随着对胰高血糖素样肽-1(glucagon-like peptide 1,GLP-1)越来越深入的研究,部分药物应用于临床,研究者们发现GLP-1不仅具有降糖作用,还可以减轻体重、改善血脂,达到直接或间接的心血管保护效应。目前GLP-1对心血管的效应愈来愈受到学者们的关注,本文对GLP-1的心血管保护效应从直接作用,间接作用,及临床应用方面进行综述。
引用
收藏
页码:5 / 7
页数:3
相关论文
共 9 条
[1]
葡萄糖诱导人血管内皮细胞凋亡及其对bax和bcl-2表达的影响 [J].
黄雌友 ;
文格波 ;
曹仁贤 ;
刘江华 ;
欧阳贵 .
中国糖尿病杂志, 2003, (01)
[2]
血游离脂肪酸水平对SD大鼠主动脉舒张功能的影响 [J].
余叶蓉 ;
朱锦舒 ;
吴永刚 ;
Alain D Baron .
中华内分泌代谢杂志, 2002, (01)
[3]
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial [J].
Garber, Alan ;
Henry, Robert ;
Ratner, Robert ;
Garcia-Hernandez, Pedro A. ;
Rodriguez-Pattzi, Hiromi ;
Olvera-Alvarez, Israel ;
Hale, Paula M. ;
Zdravkovic, Milan ;
Bode, Bruce .
LANCET, 2009, 373 (9662) :473-481
[4]
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) PROTECTS AGAINST METHYLGLYOXAL-INDUCED PC12 CELL APOPTOSIS THROUGH THE PI3K/Akt/mTOR/GCLc/REDOX SIGNALING PATHWAY [J].
Kimura, R. ;
Okouchi, M. ;
Fujioka, H. ;
Ichiyanagi, A. ;
Ryuge, F. ;
Mizuno, T. ;
Imaeda, K. ;
Okayama, N. ;
Kamiya, Y. ;
Asai, K. ;
Joh, T. .
NEUROSCIENCE, 2009, 162 (04) :1212-1219
[5]
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study [J].
Nauck, Michael ;
Frid, Anders ;
Hermansen, Kjeld ;
Shah, Nalini S. ;
Tankova, Tsvetalina ;
Mitha, Ismail H. ;
Zdravkovic, Milan ;
During, Maria ;
Matthews, David R. .
DIABETES CARE, 2009, 32 (01) :84-90
[6]
Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways.[J].Kiwon Ban;M Hossein Noyan-Ashraf;Judith Hoefer;Steffen-Sebastian Bolz;Daniel J. Drucker;Mansoor Husain.Circulation.2008, 18
[7]
GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes [J].
Gao, Hong ;
Wang, Xinjun ;
Zhang, Zhiguo ;
Yang, Yisheng ;
Yang, Jun ;
Li, Xiaoying ;
Ning, Guang .
ENDOCRINE, 2007, 32 (01) :90-95
[8]
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B [J].
Li, L ;
El-Kholy, W ;
Rhodes, CJ ;
Brubaker, PL .
DIABETOLOGIA, 2005, 48 (07) :1339-1349
[9]
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study [J].
Zander, M ;
Madsbad, S ;
Madsen, JL ;
Holst, JJ .
LANCET, 2002, 359 (9309) :824-830